Blinatumomab versus historical standard therapy in pediatric patients with relapsed/refractory Ph-negative B-cell precursor acute lymphoblastic leukemia

Detalles Bibliográficos
Autores principales: Locatelli, Franco, Whitlock, James A., Peters, Christina, Chen-Santel, Christiane, Chia, Victoria, Dennis, Robyn M., Heym, Kenneth M., Katz, Aaron J., Kelsh, Michael A., Sposto, Richard, Tu, Huakang, Tuglus, Catherine A., Verma, Anupam, Vinti, Luciana, Wilkes, Jennifer J., Zubarovskaja, Nathalya, Zugmaier, Gerhard, von Stackelberg, Arend, Sun, Weili
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7449874/
https://www.ncbi.nlm.nih.gov/pubmed/32094465
http://dx.doi.org/10.1038/s41375-020-0770-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7449874/
https://www.ncbi.nlm.nih.gov/pubmed/32094465
http://dx.doi.org/10.1038/s41375-020-0770-8

Ejemplares similares